Badanie skuteczności i bezpieczeństwa batoklimabu u dorosłych z uogólnioną miastenią gravis

Generalized Myasthenia Gravis (gMG) is a chronic condition that affects the muscles, causing weakness and fatigue. This study is focused on evaluating a treatment called batoclimab, which is given as a solution for injection. The study aims to assess how effective and safe batoclimab is when used as both an initial and ongoing treatment for adults with gMG. Participants in the study will receive either batoclimab or a placebo, which looks like the treatment but does not contain the active substance.

The study is designed to compare the effects of batoclimab with the placebo by observing changes in the participants' ability to perform daily activities. This is measured using a specific score known as the Myasthenia Gravis Activities of Daily Living (MG-ADL) score. The study will follow participants over a period of time to see how their condition changes with the treatment. The goal is to determine if batoclimab can improve the symptoms of gMG and help patients manage their daily activities better.